Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Spleen RNA-seq from 20181203 Mouse 7d IL-33 Experiment with Wild Type (WT) and IL13-/- mice

ABSTRACT: Spleen RNA-seq from 20181203 Mouse 7d IL-33 Experiment with Wild Type (WT) and IL13-/- mice

PROVIDER: PRJNA730336 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14560130.fastq.gz	Fastqsanger.gz
	SRR14560131.fastq.gz	Fastqsanger.gz
	SRR14560132.fastq.gz	Fastqsanger.gz
	SRR14560133.fastq.gz	Fastqsanger.gz
	SRR14560134.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Spleen RNA-seq from 20181203 Mouse 7d IL-33 Experiment with Wild Type (WT) and IL13-/- mice

Project description:The purpose of this study is to evaluate gene expression differences between spleens of WT and IL13-/- mice treated with either IL-33 or PBS vehicle. In addition, RNA-seq will allow us to clearly decipher the isoforms of ST2 transcript.

2021-05-17 | GSE174513 | GEO

RNA sequencing experiment of S. Cerevisiae strain CEN.PK113-7D in four different chemostat conditions

Project description:The RNA sequencing experiment was performed in four different chemostat conditions as control for a CAGE sequencing experiment performed in the same conditions using the industrial relevant S. Cerevisiae strain CEN.PK113-7D

2019-01-03 | E-MTAB-6722 | biostudies-arrayexpress

IL13 and CCL2 drive disease in an inflammatory subset of Scleroderma [IL13]

Project description:Scleroderma is a lethal and currently irreversible autoimmune disease characterized by widespread tissue fibrosis and vasculopathy. Using cross-species comparative gene expression profiling we show that murine sclerodematous graft-versus-host disease (sclGVHD) approximates an “inflammatory” subset of human scleroderma and that both diseases demonstrate activation of the IL13 cytokine pathway. We report that both host myeloid cells expressing type I and II activated macrophage markers and graft T-cells produce IL13 and that host mice deficient in either IL13 or IL4Ra, an IL13 signal transducer, are protected from disease. This signaling pathway converges on a single gene, CCL2, which is coordinately upregulated in sclGVHD, in the human inflammatory scleroderma subset and in IL13 treated human dermal fibroblasts. Accordingly, treatment with antibodies to CCL2, and its murine homolog CCL12, prevent sclGVHD. Lastly, we provide evidence that IL13 pathway activation in early scleroderma patients correlates with modified Rodnan skin scores (mRSS). These data indicate that an inflammatory subset of scleroderma is driven by IL13 and may benefit from IL13 or CCL2 blockade.

2011-06-30 | GSE24403 | GEO

IL13 and CCL2 drive disease in an inflammatory subset of Scleroderma [IL13]

2011-06-30 | E-GEOD-24403 | biostudies-arrayexpress

CAGE experiment of S. Cerevisiae strain CEN.PK113-7D in four different chemostat conditions

Project description:The CAGE experiment was performed in four different chemostat conditions to assess if and how much the Transcription start site landscape changes in the industrial relevant S. Cerevisiae strain CEN.PK113-7D in different conditions. CAGE was also used to obtain accurate TSS annotations for each expressed gene.

2019-01-03 | E-MTAB-6650 | biostudies-arrayexpress

Mixing Experiment - Mouse Kidney and Spleen

Project description:The design of this experiment was based on the assumption that transcript levels will change linearly while going from 100 percent of one tissue to 100 percent of the other. This assumed linear data set could be used to evaluate various issues related to low-level microarray data analysis. Hybridization cocktails from two mouse tissues, kidney and spleen, were prepared and mixed in a range of ratios and applied to 4-5 replicate GLYCOv1 chips for analysis. The mixture ratios were as follows: 100 percent kidney, 75 percent Kidney/25 percent spleen, 50 percent kidney/50 percent spleen, 25 percent kidney/75 percent spleen, and 100 percent spleen.

2011-03-02 | E-GEOD-27587 | biostudies-arrayexpress

RNA-Sequencing of ST2+ Treg cells in response to IL-33 stimulation

Project description:The effects of IL-33 on ST2+ Treg cells were not studied thouroughly. We FACS-sorted in vitro expanded ST2+ Treg cells from C57BL/6 Foxp3-IRES-mRFP (B6 FIR) mice. We next used RNA-seq techonology to define how recombinant IL-33 (rIL-33) may impact mouse Treg by to assessing the transcriptome of IL-33-stimulated ST2+ Treg cells compared to that of untreated ST2+ Treg cells. Our data revealed that ST2+ Treg stimulated with rIL-33 for 6 hours exhibited increased expression of Il10 and Il13 compared to unstimulated ST2+ Treg cells.

2019-05-17 | GSE123922 | GEO

CAGE experiment of S. Cerevisiae strain CEN.PK113-7D in four different chemostat conditions

Project description:CAGE experiment of S. Cerevisiae strain CEN.PK113-7D in four different chemostat conditions

| PRJEB25845 | ENA

The impact of IL-33 on Srebf2-dependent cholesterol gene expression in ST2+ eVAT Tregs

Project description:Tregs are highly enriched in the eVAT of male mice. We show that ST2+ VAT Tregs preferentially upregulate and depend on Srebf2-mediated cholesterol metabolism compared their spleen Treg or ST2- VAT Treg counterparts. However, it is unclear whether this increased reliance on cholesterol metabolism is a consequence elevated IL-33 signaling in ST2+ Tregs. Therefore, the goal of experiment is to determine whether IL-33 signaling influences Srebf2-dependent cholesterol gene expression in ST2+ eVAT Tregs in vivo.

2025-01-10 | GSE272435 | GEO

RNA sequencing experiment of S. Cerevisiae strain CEN.PK113-7D in four different chemostat conditions

Project description:RNA sequencing experiment of S. Cerevisiae strain CEN.PK113-7D in four different chemostat conditions

| PRJEB26460 | ENA